 |
| Brazil cardiac pacemakers market |
The Brazil cardiac pacemakers market
comprises devices which are implanted inside the body to regulate abnormal
heartbeats and help maintain proper rhythm of the heart. Cardiac pacemakers
find wide application in curing conditions like heart blocks, bradycardia, and
arrhythmias. They help improve quality of life of patients suffering from
cardiovascular diseases. There has been a rise in the prevalence of heart
ailments like coronary heart diseases, stroke, and cardiomyopathy in Brazil.
According to estimates, over 15 million adults have some form of cardiovascular
condition in the country. This has bolstered demand for pacemaker implantation procedures.
The Brazil cardiac pacemakers market is estimated to be valued at US$ 368.44 Bn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period
2024 to 2030.
Key Takeaways
Key players operating in the Brazil Cardiac Pacemakers are STEMCELL
Technologies Inc., Merck KGaA, Mill Creek Life Sciences, Merck & Co., Inc,
AventaCell BioMedical, Compass Biomedical, Inc, Macopharma SA, Trinova Biochem
GmbH, PL BioScience GmbH, Cook Regentec, Life Science Group Ltd., BBI
Solutions, Regenexx, Thermo Fisher Scientific. There is a rise in the number of
CVD patients undergoing pacemaker implantation annually in Brazil. Market
players are focusing on offering innovative pacing technologies, remote
monitoring cardiac devices and miniaturized pacemakers to gain competitive
advantage.
Key opportunities in the Brazil
Cardiac Pacemakers Market Size exist in the form of mergers and
acquisitions of local companies by global industry giants. Market players are
investing heavily in R&D to develop newer generations of pacemakers that
can operate for longer durations without battery replacement. The market is
witnessing increased adoption of MRI-compatible pacemakers which allow scanning
of implanted patients.
Globally, the cardiac pacemakers market players are expanding their presence in
developing economies of Asia Pacific and Latin America seeing rapid growth.
Manufacturers are focusing on obtaining regulatory approvals and setting up
production and distribution networks in high potential countries like Brazil and
Mexico. Customized product offerings catering to local needs along with
competitive pricing will help companies penetrate deeper in the Brazilian
cardiac pacemakers space.
Market drivers:
- Rising Geriatric Population: The elderly above 65 years are more prone to
heart disorders. With over 15% of Brazil's population falling in this age
bracket, need for pacemakers is surging.
- Growing Healthcare Expenditure: Government has increased healthcare funding
to strengthen cardiovascular care infrastructure and make treatment affordable.
This favors pacemaker adoption.
Market restraints:
- High Cost of Technologically Advanced Devices: Novel implantable cardioverter
defibrillators and MRI-compatible pacemakers are very expensive restricting
widespread usage.
- Lack of Awareness: Many areas in Brazil have limited availability of skilled
cardiac specialists and lesser awareness about importance of regular check-ups.
This hinders pacemaker penetration.
Segment Analysis
The Brazil cardiac pacemakers market can be segmented into implantable cardiac
pacemakers and external cardiac pacemakers. Among these, the implantable
cardiac pacemakers segment dominated the market and accounted for around 95%
share in 2024. Implantable pacemakers provides advantages such as long battery
life, convenience, and comfortable as they are implanted under the skin. Hence,
they are more preferred by patients and physicians which has led the
implantable segment to dominate the market.
Global Analysis
Regionally, the Brazil cardiac pacemakers market is dominated by South region.
The South region accounted for around 45% share of the total Brazil market in
2024 owing to presence of large patient pool and higher healthcare
infrastructure in states like Sao Paulo and Rio de Janeiro. The North and
Northeast regions are growing at a fastest pace during the forecast period due
to increasing healthcare expenditure and government initiatives to improve
access to healthcare in these regions.
Get More Insights On This Topic: Brazil
Cardiac Pacemakers Market